FDA Approves Spinal Cord Stimulation System

A PPM Brief

Nevro Corp (Redwood City, CA) earned FDA approval for its Senza II Spinal Cord Stimulation System, which delivers HF10 therapy. "The reduced size and optimized design of the Senza II IPG allow for greater patient comfort and placement options. Most importantly, it delivers HF10 therapy, a non-opioid treatment option that provides profound and paresthesia-free pain relief for patients," said Dr. Tom Simopoulos, director of Pain Medicine and Co-Director of the Spine Center at the Beth Israel Deaconess Medical Center, Boston, in a company release.

The company’s HF10 therapy, which provides electrical pulses to the spinal cord for pain relief via a compact, battery-powered generator implanted under the skin, has demonstrated relief for back and leg pain. The Senza system first received FDA premarketing approval in 2015.